Chemed Corp. vs DaVita
Chemed Corp. (CHE) and DaVita (DVA) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $7.14B
- Last close
- $548.59
- 12 months
- +27.8%
- Market value
- $10.1B
- Last close
- $161.03
- 12 months
- +39.6%
At a glance
- The biggest part of Chemed Corp.'s revenue is VITAS (64%); at DaVita it is U S Dialysis (86%).
- By market value, DaVita ($10.1B) is about 1.4 times Chemed Corp. ($7.1B).
- Over the last 12 months Chemed Corp.'s share price moved +27.8% and DaVita's +39.6%; against the S&P 500 that is +22.1 points and +33.9 points.
- In their last fiscal years Chemed Corp. kept 10.5% of revenue as net income and DaVita 5.5%.
- In the last 90 days insiders reported 0 open-market purchases at Chemed Corp. and 0 at DaVita; members of Congress disclosed 0 trades in Chemed Corp. and 0 in DaVita.
- Next results: Chemed Corp. Feb 23, 2027, DaVita Feb 1, 2027.
How each one makes money: Chemed Corp. revenue · DaVita revenue
Share prices on one chart
Chemed Corp. and DaVita, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Chemed Corp. CHENYSE · Health Care Services | DaVita DVANYSE · Health Care Services | |
|---|---|---|
| Size and profitability | ||
| Market value | $7.14B | $10.1B |
| Revenue, last fiscal year | $2.53B | $13.6B |
| Net income, last fiscal year | $265M | $747M |
| Net marginNet income as a share of revenue | 10.5% | 5.5% |
| Free cash flow | $325M | $1.31B |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
DaVita against
Common questions
How is Chemed Corp. different from DaVita?
Chemed Corp. (CHE) is in Health Care Services on NYSE, with $2.53B of revenue in its last fiscal year and a net margin of 10.5%. DaVita (DVA) is in Health Care Services on NYSE, with $13.6B of revenue in its last fiscal year and a net margin of 5.5%. The biggest part of Chemed Corp.'s revenue is VITAS (64%); at DaVita it is U S Dialysis (86%). The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Chemed Corp. and DaVita compare in size?
DaVita has the larger market value: Chemed Corp. $7.14B and DaVita $10.1B, at the last close.
Whose share price rose more over the last 12 months, CHE or DVA?
Over the last 12 months Chemed Corp. moved +27.8% and DaVita +39.6%. Past price moves say nothing about the future.
Which has had more insider buying, Chemed Corp. or DaVita?
Since 2006, DaVita insiders reported 206 open-market purchases against 53 for Chemed Corp.. These are counts of what was filed, not a view on either stock.
Do members of Congress trade CHE or DVA?
In the last 12 months, members of Congress disclosed 0 trades in Chemed Corp. (CHE) and 3 in DaVita (DVA).
When did insiders last buy CHE and DVA?
Chemed Corp.: Aug 5, 2025. DaVita: Nov 1, 2022.
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Chemed Corp. pageDaVita pageRare insider trades this weekAll comparisons
https://oqro.io/compare/che-vs-dva



